UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 116

Sortiert nach

Kierkegaard: Sobre el proceso y la paradoja en Temor y temblor

Revista de filosofía (México), 2020-12, Vol.53 (150), p.44-72

2020

Link zum Volltext

Verfügbarkeit prüfen

Synergistic efficacy of irinotecan and sunitinib combination in preclinical models of anaplastic thyroid cancer

Cancer letters, 2017-12, Vol.411, p.35-43

2017

Link zum Volltext

Verfügbarkeit prüfen

Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1

The journal of clinical endocrinology and metabolism, 2013-09, Vol.98 (9), p.E1465-E1473

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical and Pharmacodynamic Evaluation of Metronomic Cyclophosphamide, Celecoxib, and Dexamethasone in Advanced Hormone-refractory Prostate Cancer

Clinical cancer research, 2009-08, Vol.15 (15), p.4954-4962

2009

Link zum Volltext

Verfügbarkeit prüfen

Metronomic Ceramide Analogs Inhibit Angiogenesis in Pancreatic Cancer through Up-regulation of Caveolin-1 and Thrombospondin-1 and Down-regulation of Cyclin D1

Neoplasia (New York, N.Y.), 2012-09, Vol.14 (9), p.833-IN11

2012

Link zum Volltext

Verfügbarkeit prüfen

Vascular endothelial growth factor levels in immunodepleted plasma of cancer patients as a possible pharmacodynamic marker for bevacizumab activity

Journal of clinical oncology, 2007-05, Vol.25 (13), p.1816-1818

2007

Link zum Volltext

Verfügbarkeit prüfen

Irinotecan Synergistically Enhances the Antiproliferative and Proapoptotic Effects of Axitinib In Vitro and Improves Its Anticancer Activity In Vivo

Neoplasia (New York, N.Y.), 2011-03, Vol.13 (3), p.217-IN3

2011

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration

Pharmacogenomics, 2012-07, Vol.13 (9), p.1037-1053

2012

Link zum Volltext

Verfügbarkeit prüfen

The rs2071559 AA VEGFR-2 Genotype Frequency Is Significantly Lower in Neovascular Age-Related Macular Degeneration Patients

TheScientificWorld, 2012-01, Vol.2012, p.420190-6

2012

Link zum Volltext

Verfügbarkeit prüfen

Dating the Late Miocene marine sediments around the Southern Middle Durance Valley (Provence, SE France): new evidences for a Tortonian age

Bulletin de la Société géologique de France, 2024-06

2024

Link zum Volltext

Verfügbarkeit prüfen

Modelling of a lined tyre for predicting cavity noise mitigation

Applied acoustics, 2019-12, Vol.155, p.391-400

2019

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapeutic and antiangiogenic drugs beyond tumor progression in colon cancer: Evaluation of the effects of switched schedules and related pharmacodynamics

Biochemical pharmacology, 2019-06, Vol.164, p.94-105

2019

Link zum Volltext

Verfügbarkeit prüfen

Novel Pyrazolopyrimidine Derivatives as Tyrosine Kinase Inhibitors with Antitumoral Activity in Vitro and in Vivo in Papillary Dedifferentiated Thyroid Cancer

The journal of clinical endocrinology and metabolism, 2011-02, Vol.96 (2), p.E288-E296

2011

Link zum Volltext

Verfügbarkeit prüfen

CLM3, a Multitarget Tyrosine Kinase Inhibitor With Antiangiogenic Properties, Is Active Against Primary Anaplastic Thyroid Cancer In Vitro and In Vivo

The journal of clinical endocrinology and metabolism, 2014-04, Vol.99 (4), p.E572-E581

2014

Link zum Volltext

Verfügbarkeit prüfen

Docetaxel plus oral metronomic cyclophosphamide: A phase II study with pharmacodynamic and pharmacogenetic analyses in castration‐resistant prostate cancer patients

Cancer, 2014-12, Vol.120 (24), p.3923-3931

2014

Link zum Volltext

Verfügbarkeit prüfen

1,2-Benzisothiazole Derivatives Bearing 4‑, 5‑, or 6‑Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions

Journal of medicinal chemistry, 2016-07, Vol.59 (13), p.6547-6552

2016

Link zum Volltext

Verfügbarkeit prüfen

Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo

Oncology reports, 2018-05, Vol.39 (5), p.2306-2314

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients

Investigational new drugs, 2016-12, Vol.34 (6), p.760-770

2016

Link zum Volltext

Verfügbarkeit prüfen

Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients

Oncotarget, 2015-10, Vol.6 (30), p.28743-28754

2015

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic analysis of metronomic capecitabine in refractory metastatic colorectal cancer patients

Investigational new drugs, 2018-08, Vol.36 (4), p.709-714

2018

Link zum Volltext

Verfügbarkeit prüfen

CLM94, a Novel Cyclic Amide with Anti-VEGFR-2 and Antiangiogenic Properties, Is Active against Primary Anaplastic Thyroid Cancer in Vitro and in Vivo

The journal of clinical endocrinology and metabolism, 2012-04, Vol.97 (4), p.E528-E536

2012

Link zum Volltext

Verfügbarkeit prüfen

IL-8 and VEGFR-2 polymorphisms modulate long-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration

Pharmacogenomics, 2016, Vol.17 (1), p.35-9

2016

Link zum Volltext

Verfügbarkeit prüfen

Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies

Journal of medicinal chemistry, 2014-02, Vol.57 (4), p.1225-1235

2014

Link zum Volltext

Verfügbarkeit prüfen

CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo

Molecular and cellular endocrinology, 2014-08, Vol.393 (1-2), p.56-64

2014

Link zum Volltext

Verfügbarkeit prüfen

Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2

European journal of medicinal chemistry, 2015-10, Vol.103, p.29-43

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 116

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(110)
Mit Volltextzugriff
(112)

Publikationsform

Artikel
(115)
Tagungsberichte
(1)

Sprache

Japanisch
(13)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Kierkegaard: Sobre el proceso y la paradoja en Temor y temblor

Synergistic efficacy of irinotecan and sunitinib combination in preclinical models of anaplastic thyroid cancer

Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1

Clinical and Pharmacodynamic Evaluation of Metronomic Cyclophosphamide, Celecoxib, and Dexamethasone in Advanced Hormone-refractory Prostate Cancer

Metronomic Ceramide Analogs Inhibit Angiogenesis in Pancreatic Cancer through Up-regulation of Caveolin-1 and Thrombospondin-1 and Down-regulation of Cyclin D1

Vascular endothelial growth factor levels in immunodepleted plasma of cancer patients as a possible pharmacodynamic marker for bevacizumab activity

Irinotecan Synergistically Enhances the Antiproliferative and Proapoptotic Effects of Axitinib In Vitro and Improves Its Anticancer Activity In Vivo

Pharmacogenetics of antiangiogenic and antineovascular therapies of age-related macular degeneration

The rs2071559 AA VEGFR-2 Genotype Frequency Is Significantly Lower in Neovascular Age-Related Macular Degeneration Patients

Dating the Late Miocene marine sediments around the Southern Middle Durance Valley (Provence, SE France): new evidences for a Tortonian age

Modelling of a lined tyre for predicting cavity noise mitigation

Chemotherapeutic and antiangiogenic drugs beyond tumor progression in colon cancer: Evaluation of the effects of switched schedules and related pharmacodynamics

Novel Pyrazolopyrimidine Derivatives as Tyrosine Kinase Inhibitors with Antitumoral Activity in Vitro and in Vivo in Papillary Dedifferentiated Thyroid Cancer

CLM3, a Multitarget Tyrosine Kinase Inhibitor With Antiangiogenic Properties, Is Active Against Primary Anaplastic Thyroid Cancer In Vitro and In Vivo

Docetaxel plus oral metronomic cyclophosphamide: A phase II study with pharmacodynamic and pharmacogenetic analyses in castration‐resistant prostate cancer patients

1,2-Benzisothiazole Derivatives Bearing 4‑, 5‑, or 6‑Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions

Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo

Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients

Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients

Pharmacokinetic analysis of metronomic capecitabine in refractory metastatic colorectal cancer patients

CLM94, a Novel Cyclic Amide with Anti-VEGFR-2 and Antiangiogenic Properties, Is Active against Primary Anaplastic Thyroid Cancer in Vitro and in Vivo

IL-8 and VEGFR-2 polymorphisms modulate long-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration

Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies

CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo

Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2

Aktive Filter

Suchergebnisse filtern